Maynard Um
-
-
-
-
-
-
-
Sagimet Biosciences plans Phase 3 acne trial for second half of 2026
-
-
-
-
-
-
-
Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 56c
-
-
-
-
-
-
-
Oppenheimer Starts Sagimet Biosciences Inc (SGMT) at Outperform
-
-
-
-
-
-
-
Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 25c
-
-
444,183 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

